In a first, Alnylam reports success silencing genes in children

The data marks the first time a RNA interference drug has been proven to work in pediatric patients.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.